Visioneering Technologies (ASX:VTI) EBIT : A$-5.26 Mil (TTM As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies EBIT?

Visioneering Technologies's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was A$-2.83 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was A$-5.26 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Visioneering Technologies's annualized ROC % for the quarter that ended in Jun. 2024 was -93.01%. Visioneering Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -153.67%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Visioneering Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 1,191.84%.

Visioneering Technologies EBIT Historical Data

The historical data trend for Visioneering Technologies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies EBIT Chart

Visioneering Technologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-18.07

-11.82

-2.81

-8.23

-5.03

Visioneering Technologies Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT	Get a 7-Day Free Trial										-4.26	-3.80	-2.60	-2.42	-2.83

Competitive Comparison of Visioneering Technologies's EBIT

For the Medical Devices subindustry, Visioneering Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Visioneering Technologies's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's EV-to-EBIT falls into.

Visioneering Technologies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-5.26 Mil.

Visioneering Technologies (ASX:VTI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Visioneering Technologies's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	-5.668 * ( 1 - -0.22% )	/	( (6.205	+	6.01)	/ 2 )
=	-5.6804696	/	6.1075
=	-93.01 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	11.423	-	0.737	-	( 4.481	-	max(0, 2.623	-	10.707	+	4.481	))
=	6.205

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	9.211	-	0.453	-	( 2.748	-	max(0, 2.533	-	8.56	+	2.748	))
=	6.01

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Visioneering Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-5.668	/	( ( (0.272 + max(3.603, 0))	+	(0.223 + max(3.279, 0)) )	/	2 )
=	-5.668	/	( ( 3.875	+	3.502 )	/	2 )
=	-5.668	/	3.6885
=	-153.67 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.443	+	3.229	+	1.554)	-	(0.737	+	0	+	1.886)
=	3.603

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.69	+	2.384	+	1.738)	-	(0.453	+	0	+	2.08)
=	3.279

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Visioneering Technologies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	-5.256	/	-0.441
	=	1,191.84 %

Visioneering Technologies EBIT Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Visioneering Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Mansell Court, Suite 215, Alpharetta, GA, USA, 30076

Website

http://www.vtivision.com

Visioneering Technologies Inc is a medical device company. It designs, manufactures, sells, and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision, making it much easier for eye care professionals to fit their patients. It has two reportable segments; North America which includes its operations in the United States and Canada; and Europe/Asia Pacific which includes its operations outside North America.